Member Info for surprised

and mm's lined up 5 v 1 with the usual tight 25,000 mkt size....thems the clues, along with the Aim mkt was generally pushed down around 3-5% for most stocks on openeing, not share specific or based on buys v sells, just an mm mkt move, so to be on evens with one trade is pretty good and as above look at mm's position, all looking good from here 👍

down 4-5% before opening this morning, simply an mm move across markets , not based on buying or selling of any stocks...jusy a mkt move not CPX specific,....let em play they'll rally em back up again soon

far too cheap to sell down here, clearly,.... very cheap to buy though all things considered, med land upcoming, conversion etc etc 👍

down 4-5% before opening this morning, simply an mm move across markets , not based on buying or selling of any stocks...jusy a mkt move not CPX specific,....let em play they'll rally em back up again soon

RE: d2p technology working in US?
https://www.symphonyenvironmental.com/d2p/ it's growing 👍 👍

'the unnoticed mammoth sneaking under the hearth rug in front of everybody's eyes is.... D2P...

''Revenues from the Group's d2p anti-microbial technologies increased significantly to £0.5 million for the six months to 30 June 2018 (H1-2017: £0.0 million)''

D2P globally, domestically, pharmaceutically, industrially, there's $BILLIONS in that! There's no legislation involved!!!!

And breaking the US with their first cargo order was significant on a scale of magnitude as ever totally ignored by the investing public. D2P will be SYM's saviour and superhero. The $billion market cap will come from D2P first, D2W second...

Revenues from Symphony's d2p "designed-to-protect" technologies are significantly ahead of last year, and are expected to comfortably exceed management expectations. In Italy, our range of d2p anti-microbial gloves are listed in several large, as well as some smaller, retail outlets. Promotion campaigns are scheduled by our distributor during this October and further increases to product listings are expected to continue over the coming months.

After some smaller initial orders, the Group has now also received its first full $60,000 container order for d2p anti-microbial gloves to the USA.

''Also, and after two years of R&D and successful trials, Symphony has received an initial commercial order for d2p anti-insect additive technology with a very large global manufacturer of commercial agricultural products. The value of this first part-container order is $120,000, and the finished products made with d2p technology will be marketed globally. ''

well after a day of all stocks, as near as dammit falling yesterday, we suffered no worse than any others, equally for those observing a little closer there were more buyers than sellers and clearly a £20k bulk buyer picking up stock, a consistent factor around these levels....ignore the noise, the ever improving story looks set to continue ever improving, this is Aim, the drivers for the sp are numerous and CPX is clearly better placed than ever before, the general mkt conditions are volatile however, the good sound companies will surge through it all once settled, CPX is as sound as you'll get on Aim imo and more to come, a lot more .👍

sold... 983,188 BUYS .....1,131,978
red day across mkts in general, no worries, option stocks churned, small numbers and it is a non event,,,,,,and the drop is marginal compared to some today (not cpx specific), and there are many drivers for the sp going forward over coming days/weeks etc (not hours note ) and some of them will not relate to news even......all looks good from here or hereabouts...you only need to be on your toes if you're margin trading , otherwise let it play out unless you know exactly where the tops and bottoms are...under 10p for CPX seems cheap to me ...⏰. ☕️

https://www.symphonyenvironmental.com/d2p/ it's growing 👍 👍

'the unnoticed mammoth sneaking under the hearth rug in front of everybody's eyes is.... D2P...

''Revenues from the Group's d2p anti-microbial technologies increased significantly to £0.5 million for the six months to 30 June 2018 (H1-2017: £0.0 million)''

D2P globally, domestically, pharmaceutically, industrially, there's $BILLIONS in that! There's no legislation involved!!!!

And breaking the US with their first cargo order was significant on a scale of magnitude as ever totally ignored by the investing public. D2P will be SYM's saviour and superhero. The $billion market cap will come from D2P first, D2W second...

Revenues from Symphony's d2p "designed-to-protect" technologies are significantly ahead of last year, and are expected to comfortably exceed management expectations. In Italy, our range of d2p anti-microbial gloves are listed in several large, as well as some smaller, retail outlets. Promotion campaigns are scheduled by our distributor during this October and further increases to product listings are expected to continue over the coming months.

After some smaller initial orders, the Group has now also received its first full $60,000 container order for d2p anti-microbial gloves to the USA.

''Also, and after two years of R&D and successful trials, Symphony has received an initial commercial order for d2p anti-insect additive technology with a very large global manufacturer of commercial agricultural products. The value of this first part-container order is $120,000, and the finished products made with d2p technology will be marketed globally. ''

22p+
https://twitter.com/surprised_trade/status/1054640017983897600

CPX = spire Apple Murata AVX and now TDK etc and more on the way 👍☕️

from here and with the unlimited potential of both, the new developments with d2p no legislation in the way and orders romping in and the new products insectiside etc their should be an on going increasing pipeline of contracts etc..the sp may be down at the moment but it is actually an opportunity for us all here for those following the real story and deveopments, the oxo bio degradable will take hold but is a tanker to turn and SYM are best placed to take advantage, it'll come, in the meantime d2p is racing on and will continue with US now starting etc etc...
'the unnoticed mammoth sneaking under the hearth rug in front of everybody's eyes is.... D2P...

''Revenues from the Group's d2p anti-microbial technologies increased significantly to £0.5 million for the six months to 30 June 2018 (H1-2017: £0.0 million)''

D2P globally, domestically, pharmaceutically, industrially, there's $BILLIONS in that! There's no legislation involved!!!!

And breaking the US with their first cargo order was significant on a scale of magnitude as ever totally ignored by the investing public. D2P will be SYM's saviour and superhero. The $billion market cap will come from D2P first, D2W second...

Revenues from Symphony's d2p "designed-to-protect" technologies are significantly ahead of last year, and are expected to comfortably exceed management expectations. In Italy, our range of d2p anti-microbial gloves are listed in several large, as well as some smaller, retail outlets. Promotion campaigns are scheduled by our distributor during this October and further increases to product listings are expected to continue over the coming months.

After some smaller initial orders, the Group has now also received its first full $60,000 container order for d2p anti-microbial gloves to the USA.

''Also, and after two years of R&D and successful trials, Symphony has received an initial commercial order for d2p anti-insect additive technology with a very large global manufacturer of commercial agricultural products. The value of this first part-container order is $120,000, and the finished products made with d2p technology will be marketed globally. ''

pretty obviously spelt out me thinks. :-) ..

https://twitter.com/surprised_trade/status/1053570287789359105

https://www.symphonyenvironmental.com/d2p/

the unnoticed mammoth sneaking under the hearth rug in front of everybody's eyes is.... D2P...

''Revenues from the Group's d2p anti-microbial technologies increased significantly to £0.5 million for the six months to 30 June 2018 (H1-2017: £0.0 million)''

D2P globally, domestically, pharmaceutically, industrially, there's $BILLIONS in that! There's no legislation involved!!!!

And breaking the US with their first cargo order was significant on a scale of magnitude as ever totally ignored by the investing public. D2P will be SYM's saviour and superhero. The $billion market cap will come from D2P first, D2W second...

Revenues from Symphony's d2p "designed-to-protect" technologies are significantly ahead of last year, and are expected to comfortably exceed management expectations. In Italy, our range of d2p anti-microbial gloves are listed in several large, as well as some smaller, retail outlets. Promotion campaigns are scheduled by our distributor during this October and further increases to product listings are expected to continue over the coming months.

After some smaller initial orders, the Group has now also received its first full $60,000 container order for d2p anti-microbial gloves to the USA.

''Also, and after two years of R&D and successful trials, Symphony has received an initial commercial order for d2p anti-insect additive technology with a very large global manufacturer of commercial agricultural products. The value of this first part-container order is $120,000, and the finished products made with d2p technology will be marketed globally. ''

😃☕️💼🦉🦈👍

https://twitter.com/surprised_trade/status/1053318368546185218

yup, TDK deal will have the other parties majorly concerned now, if I were in their shoes and he fact that the big players are signed up it will be time to settle, as suggested in many examples prior,the likely outcome in the majority of cases is settlement rather than costly court cases, the odds are now hugely in CPX favour, were before even more so now, so costs likely to be small now and compensation royalties far in excess ..like it

mrobotic -''Based upon the statistics that I have seen, which are out of date so represent a low-ball estimate, I anticipate punitive damages to run between USD$16.2 - $20 million. This is not pie-in-the-sky. AVX lost a single similar case a couple of years ago and were subjected to a USD$16 million order, as well as the USD $37.5 million order from Greatbatch. I'll stick to my estimate. Even at that lower level, that represents around four years turnover at a minimum in compensation.

So this financial year we await two important pieces of news, the SPIRE/APPLE re-order, and the outcome of the court cases. SPIRE/APPLE is imminent, anyone out of the share the day that RNS drops will regret it. The court cases will be squeaky bum time. The day an RNS drops with anything like the damages figures I anticipate, this SP will go wild. ''

well we had a flury of decent bying this am ..Sing still in place on the ask, typically rises if at all are suppresed when they are the only mm on the ask. come on cantors shove em off and lets make a market ...a positive one 👍

👍

that'll do me 💼

some good points pco1 , however, brokers and some involved in Aim dealings that I have dealt with leave many questions about a fair ,open free trading market....there are many levels of beaviour and where folk and money mix ......